NIH-funded research NIH-funded research

How FOXO proteins change NOTCH and JAK/STAT signaling in stem cells

Official title: Investigating fundamental signal transduction mechanisms impacted by FOXO transcription factors on NOTCH and JAK/STAT Pathways in stem cell contexts

Funded at University of Texas Rio Grande Valley · NIH-11195003 · Data updated 2026-11-12

Researchers are looking at how FOXO proteins alter important cell signals in stem cells and some cancers to learn what keeps cells in a stem-like state.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Rio Grande Valley
NIH-funded
Lab location1 site (Edinburg, United States)
Project startSeptember 20, 2024
Project endAugust 31, 2028
Funding year2025
Award (this year)$148,000
NIH project number5R16GM153687-02
Project IDNIH-11195003 on NIH RePORTER

Who could benefit from this research

Could help

People with stem-cell-driven cancers (for example glioblastoma) or patients able to donate tissue or blood samples to research would be most relevant to this work.

Less likely to help

Patients seeking an immediate new treatment are unlikely to benefit directly because this is laboratory research focused on basic mechanisms.

What this research studies

This project uses lab-based experiments to see where FOXO proteins bind DNA and how they change NOTCH and JAK/STAT signaling in stem cells. Scientists will work with cell models and molecular methods such as chromatin accessibility mapping to track changes in gene activity. The team will focus on contexts relevant to tissue repair and cancers that rely on stem-like cells, including glioblastoma. Findings aim to reveal the molecular switches that keep cells from differentiating or that promote tumor-driving cell states.

Why it matters

Potential benefit: If successful, the work could point to new molecular targets to block cancer-driving stem cells or improve tissue regeneration strategies.

How similar studies have gone: Previous laboratory studies have shown FOXO factors influence stem-like behavior in embryonic cells and some cancers, but the detailed links to NOTCH and JAK/STAT signaling are still being worked out.

Where this research is happening

  • University of Texas Rio Grande Valley
    Edinburg, United States
    Active

Researchers

  • Principal investigator: Keniry, Megan E — University of Texas Rio Grande Valley
  • Study coordinator: Keniry, Megan E

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.